Sign in

Daniel Seaton

@danieldseaton.bsky.social
400 followers 334 following 4 posts

Human genetics and genomics in drug discovery.

PostsRepliesMedia
Reposted by Daniel Seaton
Stegle Lab @steglelab.bsky.social · 07/11/2025
Are you using any of our factor models, such as MOFA? 🛵 You might’ve found it challenging to tailor them to your specific use cases - not anymore! Introducing MOFA-FLEX: a flexible, modular factor analysis framework designed for customizable modeling across diverse multi-omics data scenarios. 1/n
13412
Reposted by Daniel Seaton
Diego del Alamo @delalamo.xyz · 24/04/2025
An interesting "what have we been doing all these years?" result from this paper is how sub-optimal the widely-used uniform sampling scheme can be (cluster all @50%, sample from all clusters equally). In contrast, strategies that account for the relative differences in cluster size improve val loss
(c) Diversity of PPA-1 data distributions as measured by the CDF of 50% ID cluster sizes.
(d) Validation losses of 1.4B parameter models trained on 80B tokens from different data distributions.
1122
Reposted by Daniel Seaton
Anshul Kundaje @anshulkundaje.bsky.social · 18/04/2025
Single task, lightweight, short-context bp res. profile models often perform on par or outperform current large, multi task, long context models on counterfactual prediction. Much to do to improve. Bonus: robust, efficient interpretation of syntax Great collab with @jengreitz.bsky.social lab.
0244
Reposted by Daniel Seaton
Anna Cuomo @annasecuomo.bsky.social · 24/03/2025
📢 new preprint alert: So so excited to share our analysis on the impact of common and rare variants on single-cell gene expression in blood, using WGS and scRNA-seq data from nearly 2,000 individuals and 5.4m cells as part of TenK10K phase 1 🧬 www.medrxiv.org/content/10.1... 🧵👇 (1/n)
210131
Daniel Seaton @danieldseaton.bsky.social · 06/03/2025
Are you a postgraduate student interested in protein modelling and drug discovery? We have an exciting opportunity to join our team at GSK for a 6-9 months internship, working on an ambitious cross-department research project. Apply before March 14th! www.linkedin.com/jobs/view/41...
linkedin.com
GSK hiring Computational Biologist in Stevenage, England, United Kingdom | LinkedIn
Posted 11:13:48 PM. Site Name: UK - Hertfordshire - Stevenage, Heidelberg - OfficePosted Date: Feb 28 2025We create a…See this and similar jobs on LinkedIn.
167
Reposted by Daniel Seaton
Kaur Alasoo @kauralasoo.bsky.social · 30/12/2024
Very cool paper from Eddie Park and Yi Xing studying the relationship between intron retention QTLs and expression QTLs. Predictably, genetically regulated intron retention can cause changes in gene expression via nonsense-mediated decay (NMD). www.biorxiv.org/content/10.1...
biorxiv.org
Origins and Implications of Intron Retention Quantitative Trait Loci in Human Tissues
Intron retention is a type of alternative splicing in which introns remain unspliced in mature RNA transcripts. In order to explore the landscape and consequences of genetically regulated intron reten...
1214
Reposted by Daniel Seaton
Anshul Kundaje @anshulkundaje.bsky.social · 25/12/2024
Our ChromBPNet preprint out! www.biorxiv.org/content/10.1... Huge congrats to Anusri! This was quite a slog (for both of us) but we r very proud of this one! It is a long read but worth it IMHO. Methods r in the supp. materials. Bluetorial coming soon below 1/
biorxiv.org
ChromBPNet: bias factorized, base-resolution deep learning models of chromatin accessibility reveal cis-regulatory sequence syntax, transcription factor footprints and regulatory variants
Despite extensive mapping of cis-regulatory elements (cREs) across cellular contexts with chromatin accessibility assays, the sequence syntax and genetic variants that regulate transcription factor (T...
723189
Reposted by Daniel Seaton
Jeff Spence @jeffspence.github.io · 17/12/2024
What do GWAS and rare variant burden tests discover, and why? Do these studies find the most IMPORTANT genes? If not, how DO they rank genes? Here we present a surprising result: these studies actually test for SPECIFICITY! A 🧵on what this means... (🧪🧬) www.biorxiv.org/content/10.1...
biorxiv.org
Specificity, length, and luck: How genes are prioritized by rare and common variant association studies
Standard genome-wide association studies (GWAS) and rare variant burden tests are essential tools for identifying trait-relevant genes. Although these methods are conceptually similar, we show by anal...
420695
Reposted by Daniel Seaton
Stegle Lab @steglelab.bsky.social · 09/12/2024
We are the Stegle Lab: A bioinformatics group advancing computational methods to study molecular variations and their impact on phenotypes. We are jointly hosted at the German Cancer Research Center (@dkfz.bsky.social) and the European Molecular Biology Laboratory (@embl.org) in Heidelberg, Germany.
0205
Reposted by Daniel Seaton
Na Cai @caina89.bsky.social · 04/12/2024
New work by Andy Dahl and Michal Sadowski on using GxE to study genetics of drug response now out in Cell Genomics www.cell.com/cell-genomic...
cell.com
Characterizing the genetic architecture of drug response using gene-context interaction methods
Sadowski et al. propose a framework to study the genetics of response to commonly prescribed drugs in large biobanks. They quantify the heritability of response to statins, metformin, warfarin, and methotrexate, and identify associated genes. Their analysis also shows the importance of accounting for drug use in genetic risk prediction.
12912
Reposted by Daniel Seaton
bioRxiv Genomics @biorxiv-genomic.bsky.social · 28/11/2024
Paired CRISPR screens to map gene regulation in cis and trans www.biorxiv.org/content/10.1101/202…
biorxiv.org
Paired CRISPR screens to map gene regulation in cis and trans https://www.biorxiv.org/content/10.1101/2024.11.27.625752v1
Recent massively-parallel approaches to decipher gene regulatory circuits have focused on the discov
03614
Reposted by Daniel Seaton
bioRxiv Genomics @biorxiv-genomic.bsky.social · 29/11/2024
Cross-tissue isoform switches by human transcription factors suggest a widespread regulatory mechanism www.biorxiv.org/content/10.1101/202…
biorxiv.org
Cross-tissue isoform switches by human transcription factors suggest a widespread regulatory mechanism https://www.biorxiv.org/content/10.1101/2024.11.28.625692v1
Many human genes, including transcription factor (TF) genes, produce alternative coding isoforms. Al
0226
Reposted by Daniel Seaton
Why @why.bsky.world · 20/11/2024
To be clear, we do have plans for scaling, we just kinda expected more than a couple days notice before getting blasted with a million new users a day. The team is rapidly deploying fixes and new software to adapt. More servers in the mail.
1546379012919
Reposted by Daniel Seaton
Hilary Martin @hilarycmartin.bsky.social · 20/11/2024
My group's work dissecting the contribution of common variants to rare neurodevelopmental conditions is now out at nature.com/articles/s41..., led by co-first authors Qinqin Huang (not yet on blue sky) and @emiliewigdor.bsky.social . See below for Emilie's tweetorial.
nature.com
Examining the role of common variants in rare neurodevelopmental conditions - Nature
Patients with neurodevelopmental conditions without a monogenic diagnosis have a higher polygenic burden than those with a monogenic diagnosis. Non-transmitted common all...
712442
Reposted by Daniel Seaton
EMBL-EBI @ebi.embl.org · 19/11/2024
Not enough bioinformatics in your Bluesky feed? We’ve got you covered. Follow us for our latest news, exciting life science research, updates from our data resources, new tools and training resources. Haven't heard of EMBL-EBI? Take a look at what we’re working on. www.ebi.ac.uk/about/our-im...
ebi.ac.uk
Our impact
We provide open data that helps scientists understand life and that informs solutions to real-world problems, such as infectious diseases, climate change and food security.
07931
Reposted by Daniel Seaton
Jason Buenrostro @jbuenrostro.bsky.social · 19/11/2024
Hey, a question for the genetics community. Does genetic fine-mapping work well? How often does it miss? We usually find that most fine-mapped variants do not fall within coding or regulatory regions. Is it a limitation of epigenomics or a limitation of fine-mapping? Please share your thoughts!
106821
Reposted by Daniel Seaton
Axel Visel @axelvisel.bsky.social · 27/05/2024
REX - a mammalian "range extender" element that can turn short-distance enhancers into long-distance enhancers. New preprint from a collaboration led by Grace Bower and Evgeny Kvon. doi.org/10.1101/2024...
Schematic overview of the proposed mode of action of the newly discovered REX element. Top: An enhancer can activate a gene at a short distance, but not at at long range. Middle: Presence of (C/T)AATTA motifs within an enhancer enable it to act over long distances. Bottom: Coupling a short-range enhancer to the REX element containing the same motifs turns it into a long-range enhancer.
25421
Reposted by Daniel Seaton
Michael Love @mikelove.bsky.social · 02/11/2023
Josh Weinstock @joshweinstock.bsky.social at ASHG on inferring GRN from perturbation data www.biorxiv.org/content/10.1...
biorxiv.org
Gene regulatory network inference from CRISPR perturbations in primary CD4+ T cells elucidates the g...
bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
082
Reposted by Daniel Seaton
Anna Cuomo @annasecuomo.bsky.social · 31/10/2023
Sad to be missing #ASHG23, but check out the talk by the brilliant Wei Zhou talk on Saturday on our new scalable & efficient method for single-cell eQTL mapping!
1154
Reposted by Daniel Seaton
Jeffrey Barrett @jeffbarrett.eu · 31/10/2023
This is tremendous news, and the quote that "UK Biobank is the world’s most significant resource for health research" is not an exaggeration. Very happy to see it continue to be sustained, especially as we're doing a workshop tomorrow at #ASHG23 on how to use these data! www.gov.uk/government/n...
0103
Reposted by Daniel Seaton
Kaur Alasoo @kauralasoo.bsky.social · 29/10/2023
Unfortunately I have to miss #ASHG23 this year, but if you are interested in our group's work, do check out these two posters from Ralf Tambets and Krista Freimann:
111
Reposted by Daniel Seaton
Sasha Gusev @sashagusevposts.bsky.social · 27/10/2023
Presentations from our group at ASHG next week:
172
Reposted by Daniel Seaton
Keith Robison @omicsomics.bsky.social · 24/10/2023
Catalogue of Long Read Tools - over 800 entries! 🧬🖥️ long-read-tools.org/table.html
long-read-tools.org
A catalogue of long read analysis tools
Long read sequencing technologies have gained rapid popularity due to their strengths over short read sequencing technologies. Here we present a catalogue of available long read sequence analysis too...
0127
Reposted by Daniel Seaton
Michael Love @mikelove.bsky.social · 26/10/2023
Abdullah @abdnahid.bsky.social first #Bioconductor package {easylift} is released in Bioc 3.18 Facilitates genomic liftover using existing Bioc tools: ranges |> easylift("hg38") Abdullah is one of the group that signed up for #tidyomics open challenges: github.com/tidyomics
github.com
tidyomics
Open organizaion of developers creating tidy-style analysis packages in R/Bioconductor and beyond. Reach out to join. - tidyomics
2158
Reposted by Daniel Seaton
Pau Badia i Mompel @paubadiam.bsky.social · 16/10/2023
Very happy to see that our review on gene regulatory networks is being featured by Nature Reviews Genetics and that it inspired its cover! 🥳 doi.org/10.1038/s415...
0217